Pilot study of the metabolism of sphingolipids and other small metabolites in blood and urine after oral intake of konjac ceramides

Pilot study of the metabolism of sphingolipids and other small metabolites in blood and urine after oral intake of konjac ceramides - Metabolism of sphingolipids and metabolites after oral intake of konjac ceramides

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035518

Enrollment

Registered

2019-04-01

Start date

2019-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy adult

Interventions

Single intake of konjac ceramide tablet and observation of metabolites before and after the intake every 6 hours for 24 hours, and continuous intake of konjac ceramide tablet for 3 months and observat

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: healthy volunteers without any diseases under treatment.

Exclusion criteria

Exclusion criteria: Persons who are under clinical treatment for any kinds of diseases.

Design outcomes

Primary

Measure	Time frame
Quantitative analysis of sphingolipids by targeted analysis using liquid chromatography-mass spectrometry.	—

Secondary

Measure	Time frame
Qualitative analysis of small metabolites by u targeted analysis using liquid chromatography-mass spectrometry.	—

Countries

Japan

Contacts

Public ContactHideru Obinata

Gunma University Gunma University Initiative for Advance Research

obi-tky@umin.ac.jp027-220-7908

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026